Targeting dendritic cells with antigen-containing liposomes: antitumour immunity
Dendritic cells (DCs) are antigen-presenting cells that play an important role in the body's immune defence against cancer. Strategies using antigen-primed DCs as tumour vaccines show promise in patients, but the approach is cumbersome to use clinically.
|Collections||ANU Research Publications|
|Source:||Expert Opinion on Biological Therapy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.